Neuroinflammation

Neuroinflammation is a complex process that has been noted in multiple neurological disease states such as brain injuries, infectious disease, and neurodegenerative disorders. Microglia and other cell types are activated and initiate a pro inflammatory response. Here is the latest research on neuroinflammation.

April 16, 2021
Preprint
Open Access

Extracellular Hsp90α Detoxifies β-Amyloid Fibrils Through an NRF2 and Autophagy Dependent Pathway

BioRxiv : the Preprint Server for Biology
A. MurshidStuart K Calderwood
April 16, 2021
Preprint
Open Access

The Alzheimer's disease risk factor APOE4 drives pro-inflammation in human astrocytes via HDAC-dependent repression of TAGLN3

BioRxiv : the Preprint Server for Biology
L. ArnaudEmmanuel Nivet
April 16, 2021
Preprint
Open Access

Constitutively active SARM1 variants found in ALS patients induce neuropathy

BioRxiv : the Preprint Server for Biology
Joseph BloomA. DiAntonio
April 16, 2021

The mTOR/NF-κB Pathway Mediates Neuroinflammation and Synaptic Plasticity in Diabetic Encephalopathy.

Molecular Neurobiology
Ting XuYi Liu
April 16, 2021
Open Access

Gene Expression Signature of Traumatic Brain Injury.

Frontiers in Genetics
Yawen MaYixue Xue
April 16, 2021
Open Access

A longitudinal analysis of brain extracellular free water in HIV infected individuals.

Scientific Reports
Md Nasir UddinGiovanni Schifitto
April 16, 2021

Paeoniflorin ameliorates neuropathic pain-induced depression-like behaviors in mice by inhibiting hippocampal neuroinflammation activated via TLR4/NF-κB pathway.

The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology
Hualei BaiXiangdan Li
April 16, 2021
Open Access

Orthopedic surgery-induced cognitive dysfunction is mediated by CX3CL1/R1 signaling.

Journal of Neuroinflammation
Inja ChoBon-Nyeo Koo
April 16, 2021

Mild magnetic nanoparticle hyperthermia promotes the disaggregation and microglia-mediated clearance of Beta-amyloid plaques.

Nanomedicine : Nanotechnology, Biology, and Medicine
Eric DyneMin-Ho Kim
April 16, 2021
Review
Open Access

Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses.

The Lancet. Respiratory Medicine
Woo-Jung SongKian Fan Chung

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/neuroinflammation/a62227c7-9eb8-4ec9-9490-02777a7468a8